OOIR: Observatory of International Research

Papers

(The H4-Index of Modern Pathology is 49. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies	649
COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City	351
A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression	333
In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19	243
SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers	194
Digital pathology and artificial intelligence in translational medicine and clinical practice	186
Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data	175
Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience	171
New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia	134
Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel	117
Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia	111
Validation of a digital pathology system including remote review during the COVID-19 pandemic	105
Development of a prognostic model for mortality in COVID-19 infection using machine learning	104
Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status	101
Novel artificial intelligence system increases the detection of prostate cancer in whole slide images of core needle biopsies	101
Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer	92
TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer	89
Poorly differentiated thyroid carcinoma of childhood and adolescence: a distinct entity characterized by DICER1 mutations	88
Factors associated with myocardial SARS-CoV-2 infection, myocarditis, and cardiac inflammation in patients with COVID-19	86
DNAJB1-PRKACA fusions occur in oncocytic pancreatic and biliary neoplasms and are not specific for fibrolamellar hepatocellular carcinoma	84
Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists	80
Histopathological findings and clinicopathologic correlation in COVID-19: a systematic review	79
Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets	78
A pan-cancer analysis of PD-L1 immunohistochemistry and gene amplification, tumor mutation burden and microsatellite instability in 48,782 cases	74
Lung neuroendocrine neoplasms: recent progress and persistent challenges	74

Comparison of three PD-L1 immunohistochemical assays in head and neck squamous cell carcinoma (HNSCC)	73
Quality control stress test for deep learning-based diagnostic model in digital pathology	70
DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma	66
Spitz melanoma is a distinct subset of spitzoid melanoma	65
Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer	62
Prediction of early recurrence of hepatocellular carcinoma after resection using digital pathology images assessed by machine learning	61
Counting mitoses: SI(ze) matters!	61
Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancer	60
Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer	60
Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC)	60
Retained mismatch repair protein expression occurs in approximately 6% of microsatellite instability-high cancers and is associated with missense mutations in mismatch repair genes	59
Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies	59
Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization	58
Histiocytic hyperplasia with hemophagocytosis and acute alveolar damage in COVID-19 infection	57
Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases	56
NTRK insights: best practices for pathologists	55
NTRK3 overexpression in undifferentiated sarcomas with YWHAE and BCOR genetic alterations	53
Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions	53
Clinicopathological significance of deficient DNA mismatch repair and MLH1 promoter methylation in endometrioid endometrial carcinoma	52
An independent assessment of an artificial intelligence system for prostate cancer detection shows strong diagnostic accuracy	52
Mesenchymal tumors of the gastrointestinal tract with NTRK rearrangements: a clinicopathological, immunophenotypic, and molecular study of eight cases, emphasizing their distinction from gastrointesti	51
NTRK gene rearrangements are highly enriched in MLH1/PMS2 deficient, BRAF wild-type colorectal carcinomas—a study of 4569 cases	50
HER2-low breast cancers: incidence, HER2 staining patterns, clinicopathologic features, MammaPrint and BluePrint genomic profiles	50
ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217	49